ID   FNTB_HUMAN              Reviewed;         437 AA.
AC   P49356; B2RDX6; B4E1A0;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   10-MAY-2017, entry version 171.
DE   RecName: Full=Protein farnesyltransferase subunit beta;
DE            Short=FTase-beta;
DE            EC=2.5.1.58;
DE   AltName: Full=CAAX farnesyltransferase subunit beta;
DE   AltName: Full=Ras proteins prenyltransferase subunit beta;
GN   Name=FNTB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), MUTAGENESIS OF ASP-200;
RP   GLY-249 AND GLY-349, CATALYTIC ACTIVITY, FUNCTION, AND SUBUNIT.
RC   TISSUE=Placenta;
RX   PubMed=8494894; DOI=10.1021/bi00070a028;
RA   Omer C.A., Kral A.M., Diehl R.E., Prendergast G.C., Powers S.,
RA   Allen C.M., Gibbs J.B., Kohl N.E.;
RT   "Characterization of recombinant human farnesyl-protein transferase:
RT   cloning, expression, farnesyl diphosphate binding, and functional
RT   homology with yeast prenyl-protein transferases.";
RL   Biochemistry 32:5167-5176(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Kidney, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 51-437 (ISOFORM 1/2).
RC   TISSUE=Retina;
RX   PubMed=8276393; DOI=10.1006/geno.1993.1432;
RA   Andres D.A., Milatovich A., Ozcelik T., Wenzlau J.M., Brown M.S.,
RA   Goldstein J.L., Francke U.;
RT   "cDNA cloning of the two subunits of human CAAX farnesyltransferase
RT   and chromosomal mapping of FNTA and FNTB loci and related sequences.";
RL   Genomics 18:105-112(1993).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEX WITH ZINC IONS; FNTA;
RP   FARNESYL DIPHOSPHATE AND INHIBITOR L-739,750, SUBUNIT, AND COFACTOR.
RX   PubMed=11687658; DOI=10.1073/pnas.241407898;
RA   Long S.B., Hancock P.J., Kral A.M., Hellinga H.W., Beese L.S.;
RT   "The crystal structure of human protein farnesyltransferase reveals
RT   the basis for inhibition by CaaX tetrapeptides and their mimetics.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:12948-12953(2001).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH ZINC IONS; FNTA;
RP   FARNESYL DIPHOSPHATE AND INHIBITORS, SUBUNIT, COFACTOR, CATALYTIC
RP   ACTIVITY, AND FUNCTION.
RX   PubMed=12036349; DOI=10.1021/jm010531d;
RA   Bell I.M., Gallicchio S.N., Abrams M., Beese L.S., Beshore D.C.,
RA   Bhimnathwala H., Bogusky M.J., Buser C.A., Culberson J.C., Davide J.,
RA   Ellis-Hutchings M., Fernandes C., Gibbs J.B., Graham S.L.,
RA   Hamilton K.A., Hartman G.D., Heimbrook D.C., Homnick C.F., Huber H.E.,
RA   Huff J.R., Kassahun K., Koblan K.S., Kohl N.E., Lobell R.B.,
RA   Lynch J.J. Jr., Robinson R., Rodrigues A.D., Taylor J.S., Walsh E.S.,
RA   Williams T.M., Zartman C.B.;
RT   "3-aminopyrrolidinone farnesyltransferase inhibitors: design of
RT   macrocyclic compounds with improved pharmacokinetics and excellent
RT   cell potency.";
RL   J. Med. Chem. 45:2388-2409(2002).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH ZINC IONS; FNTA;
RP   FARNESYL DIPHOSPHATE AND INHIBITOR, SUBUNIT, COFACTOR, CATALYTIC
RP   ACTIVITY, AND FUNCTION.
RX   PubMed=12825937; DOI=10.1021/jm020587n;
RA   deSolms S.J., Ciccarone T.M., MacTough S.C., Shaw A.W., Buser C.A.,
RA   Ellis-Hutchings M., Fernandes C., Hamilton K.A., Huber H.E.,
RA   Kohl N.E., Lobell R.B., Robinson R.G., Tsou N.N., Walsh E.S.,
RA   Graham S.L., Beese L.S., Taylor J.S.;
RT   "Dual protein farnesyltransferase-geranylgeranyltransferase-I
RT   inhibitors as potential cancer chemotherapeutic agents.";
RL   J. Med. Chem. 46:2973-2984(2003).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) IN COMPLEX WITH ZINC IONS; FNTA
RP   AND FARNESYL DIPHOSPHATE ANALOG, COFACTOR, AND SUBUNIT.
RX   PubMed=15451670; DOI=10.1016/j.jmb.2004.08.056;
RA   Reid T.S., Terry K.L., Casey P.J., Beese L.S.;
RT   "Crystallographic analysis of CaaX prenyltransferases complexed with
RT   substrates defines rules of protein substrate selectivity.";
RL   J. Mol. Biol. 343:417-433(2004).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) IN COMPLEX WITH ZINC IONS; FNTA
RP   AND FARNESYL DIPHOSPHATE ANALOG, CATALYTIC ACTIVITY, COFACTOR,
RP   SUBUNIT, FUNCTION, AND MUTAGENESIS OF TRP-102.
RX   PubMed=16893176; DOI=10.1021/bi060295e;
RA   Terry K.L., Casey P.J., Beese L.S.;
RT   "Conversion of protein farnesyltransferase to a
RT   geranylgeranyltransferase.";
RL   Biochemistry 45:9746-9755(2006).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) IN COMPLEX WITH ZINC IONS AND
RP   FNTA, CATALYTIC ACTIVITY, FUNCTION, COFACTOR, AND SUBUNIT.
RX   PubMed=19246009; DOI=10.1016/j.chembiol.2009.01.014;
RA   Hast M.A., Fletcher S., Cummings C.G., Pusateri E.E., Blaskovich M.A.,
RA   Rivas K., Gelb M.H., Van Voorhis W.C., Sebti S.M., Hamilton A.D.,
RA   Beese L.S.;
RT   "Structural basis for binding and selectivity of antimalarial and
RT   anticancer ethylenediamine inhibitors to protein
RT   farnesyltransferase.";
RL   Chem. Biol. 16:181-192(2009).
CC   -!- FUNCTION: Essential subunit of the farnesyltransferase complex.
CC       Catalyzes the transfer of a farnesyl moiety from farnesyl
CC       diphosphate to a cysteine at the fourth position from the C-
CC       terminus of several proteins having the C-terminal sequence Cys-
CC       aliphatic-aliphatic-X. {ECO:0000269|PubMed:12036349,
CC       ECO:0000269|PubMed:12825937, ECO:0000269|PubMed:16893176,
CC       ECO:0000269|PubMed:19246009, ECO:0000269|PubMed:8494894}.
CC   -!- CATALYTIC ACTIVITY: Farnesyl diphosphate + protein-cysteine = S-
CC       farnesyl protein + diphosphate. {ECO:0000269|PubMed:12036349,
CC       ECO:0000269|PubMed:12825937, ECO:0000269|PubMed:16893176,
CC       ECO:0000269|PubMed:19246009, ECO:0000269|PubMed:8494894}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:11687658,
CC         ECO:0000269|PubMed:12036349, ECO:0000269|PubMed:12825937,
CC         ECO:0000269|PubMed:15451670, ECO:0000269|PubMed:16893176,
CC         ECO:0000269|PubMed:19246009};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:11687658,
CC       ECO:0000269|PubMed:12036349, ECO:0000269|PubMed:12825937,
CC       ECO:0000269|PubMed:15451670, ECO:0000269|PubMed:16893176,
CC       ECO:0000269|PubMed:19246009};
CC   -!- SUBUNIT: Heterodimer of FNTA and FNTB.
CC       {ECO:0000269|PubMed:11687658, ECO:0000269|PubMed:12036349,
CC       ECO:0000269|PubMed:12825937, ECO:0000269|PubMed:15451670,
CC       ECO:0000269|PubMed:16893176, ECO:0000269|PubMed:19246009,
CC       ECO:0000269|PubMed:8494894}.
CC   -!- INTERACTION:
CC       P49354:FNTA; NbExp=11; IntAct=EBI-602349, EBI-602336;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P49356-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49356-2; Sequence=VSP_054657;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the protein prenyltransferase subunit beta
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L00635; AAA35854.1; -; mRNA.
DR   EMBL; AK303739; BAG64712.1; -; mRNA.
DR   EMBL; AK315714; BAG38073.1; -; mRNA.
DR   EMBL; AL135745; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL139022; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW80897.1; -; Genomic_DNA.
DR   EMBL; BC020232; AAH20232.1; -; mRNA.
DR   EMBL; L10414; AAA86286.1; -; mRNA.
DR   CCDS; CCDS9769.1; -. [P49356-1]
DR   PIR; B49274; B49274.
DR   RefSeq; NP_001189487.1; NM_001202558.1. [P49356-2]
DR   RefSeq; NP_002019.1; NM_002028.3. [P49356-1]
DR   UniGene; Hs.325531; -.
DR   PDB; 1JCQ; X-ray; 2.30 A; B=1-437.
DR   PDB; 1LD7; X-ray; 2.00 A; B=1-437.
DR   PDB; 1LD8; X-ray; 1.80 A; B=1-437.
DR   PDB; 1MZC; X-ray; 2.00 A; B=1-437.
DR   PDB; 1S63; X-ray; 1.90 A; B=1-437.
DR   PDB; 1SA4; X-ray; 2.10 A; B=1-437.
DR   PDB; 1TN6; X-ray; 1.80 A; B=1-437.
DR   PDB; 2F0Y; X-ray; 2.70 A; B=1-437.
DR   PDB; 2H6F; X-ray; 1.50 A; B=1-437.
DR   PDB; 2H6G; X-ray; 1.85 A; B=1-437.
DR   PDB; 2H6H; X-ray; 1.80 A; B=1-437.
DR   PDB; 2H6I; X-ray; 3.00 A; B=1-437.
DR   PDB; 2IEJ; X-ray; 1.80 A; B=1-437.
DR   PDB; 3E37; X-ray; 1.80 A; B=1-437.
DR   PDBsum; 1JCQ; -.
DR   PDBsum; 1LD7; -.
DR   PDBsum; 1LD8; -.
DR   PDBsum; 1MZC; -.
DR   PDBsum; 1S63; -.
DR   PDBsum; 1SA4; -.
DR   PDBsum; 1TN6; -.
DR   PDBsum; 2F0Y; -.
DR   PDBsum; 2H6F; -.
DR   PDBsum; 2H6G; -.
DR   PDBsum; 2H6H; -.
DR   PDBsum; 2H6I; -.
DR   PDBsum; 2IEJ; -.
DR   PDBsum; 3E37; -.
DR   ProteinModelPortal; P49356; -.
DR   SMR; P49356; -.
DR   BioGrid; 108627; 49.
DR   BioGrid; 1529403; 1.
DR   IntAct; P49356; 9.
DR   MINT; MINT-238879; -.
DR   STRING; 9606.ENSP00000246166; -.
DR   BindingDB; P49356; -.
DR   ChEMBL; CHEMBL272; -.
DR   DrugBank; DB06953; 2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE.
DR   DrugBank; DB07227; 4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE.
DR   DrugBank; DB07895; ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID.
DR   DrugBank; DB04893; AZD3409.
DR   DrugBank; DB07780; FARNESYL DIPHOSPHATE.
DR   DrugBank; DB07841; GERANYLGERANYL DIPHOSPHATE.
DR   DrugBank; DB04960; Tipifarnib.
DR   GuidetoPHARMACOLOGY; 2826; -.
DR   iPTMnet; P49356; -.
DR   PhosphoSitePlus; P49356; -.
DR   BioMuta; FNTB; -.
DR   DMDM; 1346696; -.
DR   EPD; P49356; -.
DR   MaxQB; P49356; -.
DR   PaxDb; P49356; -.
DR   PeptideAtlas; P49356; -.
DR   PRIDE; P49356; -.
DR   DNASU; 2342; -.
DR   Ensembl; ENST00000246166; ENSP00000246166; ENSG00000257365. [P49356-1]
DR   GeneID; 100529261; -.
DR   GeneID; 2342; -.
DR   KEGG; hsa:100529261; -.
DR   KEGG; hsa:2342; -.
DR   UCSC; uc001xia.4; human. [P49356-1]
DR   CTD; 100529261; -.
DR   CTD; 2342; -.
DR   DisGeNET; 2342; -.
DR   GeneCards; FNTB; -.
DR   HGNC; HGNC:3785; FNTB.
DR   HPA; HPA062743; -.
DR   MIM; 134636; gene.
DR   neXtProt; NX_P49356; -.
DR   OpenTargets; ENSG00000257365; -.
DR   PharmGKB; PA28202; -.
DR   eggNOG; KOG0365; Eukaryota.
DR   eggNOG; COG5029; LUCA.
DR   GeneTree; ENSGT00550000075042; -.
DR   HOVERGEN; HBG008173; -.
DR   InParanoid; P49356; -.
DR   KO; K05954; -.
DR   OMA; FMLRMKD; -.
DR   OrthoDB; EOG091G08TB; -.
DR   PhylomeDB; P49356; -.
DR   TreeFam; TF353162; -.
DR   Reactome; R-HSA-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   SIGNOR; P49356; -.
DR   EvolutionaryTrace; P49356; -.
DR   GeneWiki; FNTB; -.
DR   PRO; PR:P49356; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000257365; -.
DR   CleanEx; HS_FNTB; -.
DR   Genevisible; P49356; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005875; C:microtubule associated complex; IDA:BHF-UCL.
DR   GO; GO:0005965; C:protein farnesyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0008144; F:drug binding; IEA:Ensembl.
DR   GO; GO:0004311; F:farnesyltranstransferase activity; IEA:Ensembl.
DR   GO; GO:0019840; F:isoprenoid binding; IEA:Ensembl.
DR   GO; GO:0042277; F:peptide binding; IEA:Ensembl.
DR   GO; GO:0004660; F:protein farnesyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0045787; P:positive regulation of cell cycle; IEA:Ensembl.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl.
DR   GO; GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; IEA:Ensembl.
DR   GO; GO:0018343; P:protein farnesylation; IDA:UniProtKB.
DR   GO; GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0034097; P:response to cytokine; IEA:Ensembl.
DR   GO; GO:0010035; P:response to inorganic substance; IEA:Ensembl.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   CDD; cd02893; FTase; 1.
DR   InterPro; IPR026872; FTB.
DR   InterPro; IPR001330; PFTB_repeat.
DR   InterPro; IPR008930; Terpenoid_cyclase/PrenylTrfase.
DR   PANTHER; PTHR11774:SF12; PTHR11774:SF12; 1.
DR   Pfam; PF00432; Prenyltrans; 5.
DR   SUPFAM; SSF48239; SSF48239; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Metal-binding;
KW   Phosphoprotein; Prenyltransferase; Reference proteome; Repeat;
KW   Transferase; Zinc.
FT   CHAIN         1    437       Protein farnesyltransferase subunit beta.
FT                                /FTId=PRO_0000119761.
FT   REPEAT      123    164       PFTB 1.
FT   REPEAT      174    215       PFTB 2.
FT   REPEAT      222    263       PFTB 3.
FT   REPEAT      270    312       PFTB 4.
FT   REPEAT      332    374       PFTB 5.
FT   REGION      248    251       Farnesyl diphosphate binding.
FT   REGION      291    294       Farnesyl diphosphate binding.
FT   REGION      300    303       Farnesyl diphosphate binding.
FT   METAL       297    297       Zinc; catalytic.
FT   METAL       299    299       Zinc; catalytic.
FT   METAL       362    362       Zinc; via tele nitrogen; catalytic.
FT   SITE        102    102       Important for selectivity against
FT                                geranylgeranyl diphosphate.
FT   MOD_RES     436    436       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8K2I1}.
FT   VAR_SEQ       1     48       MASPSSFTYYCPPSSSPVWSEPLYSLRPEHARERLQDDSVE
FT                                TVTSIEQ -> MI (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054657.
FT   MUTAGEN     102    102       W->T: Removes the steric hindrance that
FT                                normally precludes geranylgeranyl
FT                                diphosphate binding. Reduces
FT                                farnesyltransferase activity and confers
FT                                geranylgeranyltransferase activity.
FT                                {ECO:0000269|PubMed:16893176}.
FT   MUTAGEN     200    200       D->N: Reduced catalytic efficiency.
FT                                {ECO:0000269|PubMed:8494894}.
FT   MUTAGEN     249    249       G->V: Reduced catalytic efficiency.
FT                                {ECO:0000269|PubMed:8494894}.
FT   MUTAGEN     349    349       G->S: Reduced catalytic efficiency.
FT                                {ECO:0000269|PubMed:8494894}.
FT   CONFLICT    283    283       R -> L (in Ref. 6; AAA86286).
FT                                {ECO:0000305}.
FT   HELIX        24     26       {ECO:0000244|PDB:2H6F}.
FT   HELIX        28     33       {ECO:0000244|PDB:2H6F}.
FT   HELIX        43     60       {ECO:0000244|PDB:2H6F}.
FT   HELIX        75     85       {ECO:0000244|PDB:2H6F}.
FT   STRAND       87     89       {ECO:0000244|PDB:2IEJ}.
FT   HELIX        91     96       {ECO:0000244|PDB:2H6F}.
FT   HELIX       100    113       {ECO:0000244|PDB:2H6F}.
FT   HELIX       120    133       {ECO:0000244|PDB:2H6F}.
FT   STRAND      138    143       {ECO:0000244|PDB:2H6F}.
FT   HELIX       150    163       {ECO:0000244|PDB:2H6F}.
FT   HELIX       166    169       {ECO:0000244|PDB:2H6F}.
FT   HELIX       174    182       {ECO:0000244|PDB:2H6F}.
FT   STRAND      191    194       {ECO:0000244|PDB:2H6F}.
FT   HELIX       201    213       {ECO:0000244|PDB:2H6F}.
FT   TURN        219    224       {ECO:0000244|PDB:2H6F}.
FT   HELIX       225    232       {ECO:0000244|PDB:2H6F}.
FT   STRAND      237    239       {ECO:0000244|PDB:2H6F}.
FT   HELIX       249    262       {ECO:0000244|PDB:2H6F}.
FT   HELIX       265    267       {ECO:0000244|PDB:2H6F}.
FT   HELIX       270    279       {ECO:0000244|PDB:2H6F}.
FT   TURN        283    285       {ECO:0000244|PDB:2H6F}.
FT   STRAND      287    291       {ECO:0000244|PDB:2H6F}.
FT   HELIX       300    303       {ECO:0000244|PDB:2H6F}.
FT   TURN        304    306       {ECO:0000244|PDB:2H6F}.
FT   HELIX       307    317       {ECO:0000244|PDB:2H6F}.
FT   STRAND      325    327       {ECO:0000244|PDB:2F0Y}.
FT   HELIX       332    342       {ECO:0000244|PDB:2H6F}.
FT   HELIX       360    374       {ECO:0000244|PDB:2H6F}.
FT   STRAND      375    378       {ECO:0000244|PDB:2H6F}.
FT   STRAND      381    384       {ECO:0000244|PDB:2H6F}.
FT   HELIX       390    392       {ECO:0000244|PDB:2H6F}.
FT   TURN        399    401       {ECO:0000244|PDB:2H6F}.
FT   HELIX       405    416       {ECO:0000244|PDB:2H6F}.
SQ   SEQUENCE   437 AA;  48774 MW;  8E8E571846146709 CRC64;
     MASPSSFTYY CPPSSSPVWS EPLYSLRPEH ARERLQDDSV ETVTSIEQAK VEEKIQEVFS
     SYKFNHLVPR LVLQREKHFH YLKRGLRQLT DAYECLDASR PWLCYWILHS LELLDEPIPQ
     IVATDVCQFL ELCQSPEGGF GGGPGQYPHL APTYAAVNAL CIIGTEEAYD IINREKLLQY
     LYSLKQPDGS FLMHVGGEVD VRSAYCAASV ASLTNIITPD LFEGTAEWIA RCQNWEGGIG
     GVPGMEAHGG YTFCGLAALV ILKRERSLNL KSLLQWVTSR QMRFEGGFQG RCNKLVDGCY
     SFWQAGLLPL LHRALHAQGD PALSMSHWMF HQQALQEYIL MCCQCPAGGL LDKPGKSRDF
     YHTCYCLSGL SIAQHFGSGA MLHDVVLGVP ENALQPTHPV YNIGPDKVIQ ATTYFLQKPV
     PGFEELKDET SAEPATD
//
